down arrow

Lincoln Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
552.90
14.65 (2.72%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
146.55
161.21
147.28
142.49
146.45
155.99
135.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
146.55
161.21
147.28
142.49
146.45
155.99
135.62
Raw Material Cost
50.16
57.10
52.75
51.89
56.88
49.66
42.70
Purchase of Finished goods
18.61
21.86
13.33
17.00
30.51
19.96
15.44
(Increase) / Decrease In Stocks
-0.13
-6.66
4.16
4.69
-20.30
4.20
5.71
Employee Cost
27.98
27.84
29.02
25.05
26.44
24.94
26.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
26.27
32.71
25.29
25.48
23.26
26.07
24.59
Total Expenditure (Excl Depreciation)
122.89
132.84
124.55
124.11
116.79
124.84
114.90
Operating Profit (PBDIT) excl Other Income
23.66
28.37
22.73
18.38
29.66
31.15
20.72
Other Income
8.97
9.98
10.41
7.02
11.02
8.69
7.69
Operating Profit (PBDIT)
32.63
38.35
33.14
25.40
40.68
39.84
28.41
Interest
0.73
0.35
0.44
0.50
0.15
0.39
0.42
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
31.90
38.00
32.70
24.90
40.53
39.45
27.99
Depreciation
3.22
3.22
3.22
2.69
2.81
2.58
2.55
Profit Before Tax
28.68
34.78
29.48
22.22
37.71
36.87
25.45
Tax
7.91
8.45
5.81
3.62
9.67
9.21
6.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.77
26.33
23.67
18.60
28.04
27.65
19.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.77
26.33
23.67
18.60
28.04
27.65
19.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.77
26.33
23.67
18.60
28.04
27.65
19.01
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.03
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
10.37
13.15
11.82
9.29
14.0
13.8
9.49
Diluted Earnings per share
10.37
13.15
11.82
9.28
14.0
13.81
9.49
Operating Profit Margin (Excl OI)
16.14%
17.6%
15.43%
12.9%
20.25%
19.97%
15.28%
Gross Profit Margin
21.77%
23.57%
22.2%
17.47%
27.67%
25.29%
20.64%
PAT Margin
14.17%
16.33%
16.07%
13.05%
19.15%
17.73%
14.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is -20.23% vs 10.88% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is 386.67% vs -54.55% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Lincoln Pharma. With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
146.55
3,230.00
-3,083.45
-95.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
146.55
3,230.00
-3,083.45
-95.46%
Raw Material Cost
50.16
536.11
-485.95
-90.64%
Purchase of Finished goods
18.61
387.30
-368.69
-95.19%
(Increase) / Decrease In Stocks
-0.13
11.81
-11.94
-101.10%
Employee Cost
27.98
709.71
-681.73
-96.06%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
26.27
755.27
-729.00
-96.52%
Total Expenditure (Excl Depreciation)
122.89
2,400.20
-2,277.31
-94.88%
Operating Profit (PBDIT) excl Other Income
23.66
829.80
-806.14
-97.15%
Other Income
8.97
77.32
-68.35
-88.40%
Operating Profit (PBDIT)
32.63
907.12
-874.49
-96.40%
Interest
0.73
220.93
-220.20
-99.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
31.90
686.19
-654.29
-95.35%
Depreciation
3.22
192.30
-189.08
-98.33%
Profit Before Tax
28.68
497.33
-468.65
-94.23%
Tax
7.91
112.81
-104.90
-92.99%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
20.77
381.08
-360.31
-94.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
20.77
381.08
-360.31
-94.55%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
0.00
4.29
-4.29
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.77
380.23
-359.46
-94.54%
Equity Capital
20.03
40.06
-20.03
-50.00%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
10.37
9.49
0.88
9.27%
Diluted Earnings per share
10.37
9.44
0.93
9.85%
Operating Profit Margin (Excl OI)
16.14%
25.69%
0.00
-9.55%
Gross Profit Margin
21.77%
21.24%
0.00
0.53%
PAT Margin
14.17%
11.90%
0.00
2.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 146.55 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -9.09% vs 9.46% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.77 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -21.12% vs 11.24% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.66 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -16.60% vs 24.81% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -20.23% vs 10.88% in Dec 2023

Quarterly - Interest
Interest 0.73 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 108.57% vs -20.45% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 386.67% vs -54.55% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.14%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023